Eko Health Secures $41 Million to Expand AI-Powered Stethoscope Business Globally

1. Funding Amount: Eko Health has raised $41 million in new funding to expand its AI stethoscope business globally.
2. Expansion Plans: The company aims to expand its commercial reach in the U.S. and overseas, including the EU and South Korea.
3. AI Technology: Eko Health's stethoscope captures both heart sounds and electrocardiogram readings and is connected to an AI program that can detect atrial fibrillation and heart murmurs.
4. Telehealth Focus: The company is focusing on developing its remote disease screening programs, particularly for heart and lung conditions.
5. Previous Funding: Eko Health had previously secured $65 million in a series C venture capital round in 2020 to develop its home telehealth offerings.